Competition and collaboration in health care: reconciling the irreconcilable? Lessons from The Netherlands Marco VarkevisserFrédérique FrankenErik Schut Editorial 08 July 2023 Pages: 1019 - 1021
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries Olina Efthymiadou Original Paper Open access 11 October 2022 Pages: 1023 - 1031
The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease Zuzana ŠpacírováStephen KaptogeDavid Epstein Original Paper 14 October 2022 Pages: 1033 - 1045
Estimating healthcare expenditures after becoming divorced or widowed using propensity score matching Iris MeulmanBette LoefEllen Uiters Original Paper Open access 17 October 2022 Pages: 1047 - 1060
Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy India FlintJasmina MedjedovicLouise Longworth Original Paper 19 October 2022 Pages: 1061 - 1072
Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries Przemysław HolkoPaweł KawalecMałgorzata Mossakowska Original Paper Open access 19 October 2022 Pages: 1073 - 1083
Do not PIMP my nursing home ride! The impact of Potentially Inappropriate Medications Prescribing on residents’ emergency care use Thomas RappJonathan SicsicYves Rolland Original Paper 21 October 2022 Pages: 1085 - 1100
The effects of an increase in the retirement age on health care costs: evidence from administrative data Johannes GeyerMara BarschkettAnna Hammerschmid Original Paper Open access 23 October 2022 Pages: 1101 - 1120
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study Ingrid A. CoxBarbara de GraaffAndrew J. Palmer Original Paper Open access 27 October 2022 Pages: 1121 - 1139
Can drones save lives and money? An economic evaluation of airborne delivery of automated external defibrillators Johann W. A. RöperKatharina FischerSteffen Fleßa Original Paper Open access 30 October 2022 Pages: 1141 - 1150
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review Michela MeregagliaElena NicodMichael Drummond Original Paper Open access 05 November 2022 Pages: 1151 - 1216
What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains Michał Jakubczyk Original Paper Open access 08 November 2022 Pages: 1217 - 1233
“COVID-19 and income inequality in OECD countries:” A methodological comment Oded Stark Commentary Open access 23 June 2023 Pages: 1235 - 1237
COVID-19 and income inequality in OECD countries: a methodological comment—a reply John Wildman Reply 17 June 2023 Pages: 1239 - 1241
Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment Afschin Gandjour Commentary Open access 24 June 2023 Pages: 1243 - 1244
Does health technology assessment compromise access to pharmaceuticals? Melanie BüssgenTom Stargardt Reply Open access 19 June 2023 Pages: 1245 - 1248